The Quaker Investment Alliance is an investment club that was founded in 2011 at the Wharton School of Business at the University of Pennsylvania. The five founding members have experience ranging across the entire financial industry. Through leveraging our various backgrounds and industry experience we look to continually outperform the market. We are a multi-strategy fund, separating our portfolio into both long and short term investment horizons. The long-term portion of our fund is focused on equities and uses a bottom-up, fundamental approach. This comprises the majority of our fund and acts as a stabilizer against the volatility we expect from the rest of the portfolio. We are typically against broad scale diversification because we believe that investors can manage their risk individually and that by diversifying we are significantly limiting the potential upside of the companies that we are most confident in. The short-term strategy focuses on macro analysis. We are constantly looking at the state of the greater markets and seeking out mispricings. Much of this analysis is done around key company catalysts where we believe the markets will realize and correct the mispricing. We use option strategies quite frequently on this side of the portfolio because it allows us to gain greater immediate exposure. We aim to maintain a target portfolio balance with strategic exposures that serve to keep our risk profile in check and ultimately allow us to continually beat the market. Our industry focus is very broad across both strategies. We see this as a strength because it does not limit our ability to seek out undervalued companies.
I am a physician and an Individual Investor. I try to value the endless wisdom of Jean-Marie Eveillard, Peter Cundill and Warren Buffett. I focus extensively on identifying sustainable competitive advantages, management practices and complicated business structures with difficult to value companies. I tend to concentrate on deciphering value in special situations, initial public offerings and distressed macroeconomic situations. Hence I find myself investing in emerging market equity, contrarian situations and intangible brand values.
I am gradually moving from value spotting to value creation opportunities. Simultaneously I am focusing on Small Caps with sustainable advantages to identify potential disruption opportunities. Since I only invest my personal and family finances, absolute real return with downside protection is an absolute requirement of my investment style.
Individual Investor in stocks as well as an investor and adviser to start-ups. Most of my background is in marketing and product management with some experience as a management consultant and US Navy intelligence officer. MBA and BA degrees from the University of Chicago.
I'm a retired hobbyist who's trying to trying to absorb as many new things about stock selection and investing as I can, with the goal of developing a process to outperform the market long term with reasonable risk.
I'm unsure if I'm up to the task. ;-)
I am a private investor with a broad portfolio diversified across sector and size. Most of my writing, and much of the speculative portion of my portfolio, focuses on small and mid-cap companies in the healthcare and biotechnology sector. This sector provides the opportunity for outsize rewards, though one must be willing to accept significant risk. My background has exposure to healthcare investing and involvement with operating companies, which I believe provides me with a unique perspective. Currently I am an Associate for Finance and Business development at a clinical stage oncology company called Oncoceutics. Previously I was an Analyst at Osage University Partners, a venture capital firm focused on investing in companies developing technologies licensed from universities across a broad spectrum of opportunities including life sciences, information technology, cleantech, hardware and advanced materials. Prior to that, I worked for a grant program directed at life science technology commercialization at the University City Science Center. I also have worked at BlackRock Asset Management in an operations role with the money market and municipal bond fund groups.
I have a B.S. in Finance and Entrepreneurship with a minor in Biological Sciences from Drexel University, and hold the Chartered Financial Analyst (CFA) designation.
Lee is the general partner of Qualitas Capital Management, a private investment partnership that pursues capital appreciation by seeking superior risk-adjusted investment returns. The partnership invests in the public equities of high quality firms with solid and consistent growth prospects that Lee believes are significantly undervalued based on fundamental analysis. The partnership has a flexible mandate to invest across all business sectors, global regions, and market capitalizations. The partnership typically focuses on firms that Lee believes are relatively underfollowed and often misunderstood yet have what he views as attractive businesses, valuations, and catalysts.
Prior to forming Qualitas, Lee was a portfolio manager at Gator Capital Management ("Gator Capital"). At Gator Capital, Lee was responsible for launching and solely managing the Gator Opportunities Fund (the "Fund"), an open-end equity mutual fund registered with the SEC. During Lee's tenure as portfolio manager of the Fund, he delivered annualized returns of 11.2% (Institutional Class) / 10.9% (Retail Class) from the Fund's inception and outperformed Russell 2500® Index benchmark by 573 and 545 basis points, respectively, over that period. The Fund was ranked in the top 1% of 399 funds in Morningstar's peer category in its first year from inception and in the top 13% year-to-date through October. The Fund was also ranked 10th out of 447 funds in Lipper's "category killers" table in April for year-to-date performance (Wall Street Journal, 5/4/15).
Prior to joining Gator Capital, Lee was a member of the Fundamental Equities Group at Goldman Sachs Asset Management (GSAM). Lee's responsibilities at GSAM covered the gamut of the fundamental equities investment process from idea origination, research, analysis, and implementation to portfolio sector construction and management, risk monitoring, and strategic review. While at GSAM, Lee contributed significantly to the successful launch and growth of all-cap, mid-cap, small/mid-cap, and long/short equity investment products. Lee also provided analytical coverage primarily of the industrials and technology sectors across all market capitalizations.
Prior to joining GSAM, Lee was a co-founder of Tower Hill Securities, a merchant banking firm that focused on funding global emerging growth companies across various business sectors. Prior to co-founding Tower Hill, Lee was a founding member of the strategic consultancy Mitchell Madison Group, and an associate in the Financial Institutions/Services Practice of management consulting firm A. T. Kearney. Prior to joining A. T. Kearney, Lee was also a Faculty Lecturer at Princeton University's Woodrow Wilson Schools, where he co-taught several courses in applied quantitative and economic analysis with Professors Ben Bernanke and Alan Krueger.
Lee is a Chartered Financial Analyst (CFA) and a member of the CFA Institute and New York Society of Security Analysts (NYSSA). Lee received his BA from Yale University, his MPA from Princeton University, and his MBA from Stanford University, all with the highest honors and concentrations in economics, finance, and investment management.
Started in 1997 trading my own money in futures (ouch), then options (oops), then penny stocks(darn).
Now I use fundamental and technical analysis together, and my approach is very conservative compared to my earlier losing years trading. I hold longer term positions in profitable companies using quarterly, monthly, weekly, and daily charts for timing.
Personal investor. I started investing in clean energy stocks, mostly Chinese companies, in September 2011 which was after they had generally dropped 50-75% in value. I was purchasing CSIQ, DQ, JKS, MY, and YGE at what was close to their 52 week low price, but the only problem was they continued to drop another 15-20% in price before the end of 3Q2011. Fortunately, October 2011 has been a rebound month, and overall, I have gained back most of those losses (CSIQ and DQ are yet to recover). Now, with the European Sovereign Debt Crises in a temporary holding pattern, I am waiting for the 3rd quarter earnings reports for these companies. If the reports are good, then I think these stocks will do well.
Another watch point for these stocks will be the attempt to apply trade tariffs on sales of their products in USA. If the tariffs do not happen, that will be good news. But even if the tariffs do happen, I think these companies will continue to grow and be profitable from their sales within China (which apparently is very committed to clean, renewable energy) as well as around the world.
Other stocks of interest to me: ASYS and MNTA for a bit of diversification.